BIO Board of Directors

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors.

In general, candidates interested in joining the BIO Board should serve in a senior leadership position for a research and development (R&D)-focused BIO Member company. If your organization is not a BIO member, click here to learn more about membership.

Become a BIO Member

If you have any questions about the BIO Board of Directors, please contact BIO’s Board Services Team at [email protected].

Expand All

Executive Committee of the Board

Executive Committee

Fritz Bittenbender

Chair

Senior Vice President, Genentech, A Member of the Roche Group

Frank Watanabe, MA

Vice Chair

President & CEO, Arcutis Biotherapeutics, Inc.

Ted W. Love, MD

Immediate Past Chair

Former CEO, Global Blood Therapeutics; Immediate Past Chair, BIO Board of Directors

Thomas P. Mathers

Treasurer

Executive Chairman, Aer Therapeutics, Inc.

Catherine Owen Adams

ECS Chair

CEO, ACADIA Pharmaceuticals, Inc

Eric M. Dube, PhD

ECS Vice Chair

Patient Advocacy, Travere Therapeutics, Inc.

Sulagna Bhattacharya

At-Large Member

CEO, Nanoscope Therapeutics, Inc.

Victor Bultó

At-Large Member

President, Innovative Medicines US,, Novartis Pharmaceuticals Corporation

Bradley L. Campbell

At-Large Member

President & CEO, Amicus Therapeutics, Inc.

Tom Cavanaugh

At-Large Member

Company Group Chairman, North America, Johnson & Johnson

Deborah Glasser

At-Large Member

Head Specialty Care North America and U.S. Country Lead, Sanofi

Cristin Hubbard

At-Large Member

Executive Vice President and Chief Commercial Officer, BioMarin Pharmaceutical, Inc.

Rachna Khosla

At-Large Member

Senior Vice President, Head of Business Development, Amgen Inc.

Neil Kumar, PhD

At-Large Member

CEO, BridgeBio Pharma

Joseph LaRosa, Esq

At-Large Member

Executive Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.

Chris Leibman

At-Large Member

SVP, Chief Access Officer, Biogen

Jannie Oosthuizen

At-Large Member

President, U.S. Human Health, Merck

Cindy Perettie

At-Large Member

Executive Vice President, Kite Pharma, a Gilead Company

Mike G. Raab

At-Large Member

President & Chief Executive Officer, Ardelyx Inc.

Amit Sachdev

At-Large Member

Chief Patient Officer, Vertex Pharmaceuticals Incorporated

Ilya Yuffa

At-Large Member

Executive Vice President and President of Lilly USA, Eli Lilly and Company

Cari Gallman

Secretary

Executive Vice President, General Counsel and Chief Policy Officer, Bristol Myers Squibb Company

Board of Directors

Directors

Fritz Bittenbender

Chair

Senior Vice President, Genentech, A Member of the Roche Group

Frank Watanabe, MA

Vice Chair

President & CEO, Arcutis Biotherapeutics, Inc.

Ted W. Love, MD

Immediate Past Chair

Former CEO, Global Blood Therapeutics; Immediate Past Chair, BIO Board of Directors

Thomas P. Mathers

Treasurer

Executive Chairman, Aer Therapeutics, Inc.

Catherine Owen Adams

ECS Chair

CEO, ACADIA Pharmaceuticals, Inc

Eric M. Dube, PhD

ECS Vice Chair

Patient Advocacy, Travere Therapeutics, Inc.

Vincent Andrews

Member

SVP, General Counsel, Chief Compliance Officer and Corporate Affairs, Eisai, Inc.

Bobak Azamian, MD, PhD

Member

CEO & Chairman, Tarsus Pharmaceuticals, Inc.

Martin Babler

Member

President, CEO & Chairman of the Board, Alumis, Inc.

Brad Bailey

Member

Executive Vice President and Chief Commercial Officer, Genmab

Jacob Becraft, PhD

Member

Co-Founder & CEO, Strand Therapeutics

Nessan Bermingham, PhD

Member

Operating Partner, Khosla Ventures, LLC

Sulagna Bhattacharya

Member

CEO, Nanoscope Therapeutics, Inc.

Warner Biddle

Member

CEO, Kyverna Therapeutics

Robert I. Blum, MBA

Member

President & CEO, Cytokinetics, Inc

David W. Boyer

Member

Chief Corporate Affairs Officer, Neurocrine Biosciences, Inc.

Steve Brady

Member

Chair of the Board, Tempest Therapeutics Inc.

Christine Brennan, PhD

Member

Managing Director, Vertex Ventures HC

Victor Bultó

Member

President, Innovative Medicines US,, Novartis Pharmaceuticals Corporation

John Butler

Member

President & CEO, Akebia Therapeutics, Inc.

Bradley L. Campbell

Member

President & CEO, Amicus Therapeutics, Inc.

Tom Cavanaugh

Member

Company Group Chairman, North America, Johnson & Johnson

James Choi

Member

EVP, Chief Marketing Officer and Head of Sales Support and Global Public Affairs, Samsung Biologics

Jeffrey L. Cleland, PhD

Member

President & CEO, Programmable Medicine

Grace E. Colón, PhD

Member

Chair, Board of Directors, Bloom Science, Inc.

Marianne De Backer, MBA, MSc, PhD

Member

CEO, Vir Biotechnology, Inc.

Lisa Deschamps

Member

Chief Executive Officer, AviadoBio

Doug Dieter

Member

Partner, Portfolio Manager and Co-Head, Ares Specialty Healthcare, Ares Capital

Dipal Doshi

Member

Chief Executive Officer, Entrada Therapeutics, Inc.

Marc Dunoyer

Member

Chief Executive Officer, Alexion Pharmaceuticals, Inc

Deborah Dunsire, MD

Member

Board Chair, Neurvati Neurosciences

David Esposito

Member

Chief Executive Officer, President & Board Member, ONL Therapeutics, Inc.

Alexandria Forbes, PhD

Member

President & CEO, MeiraGTx

Crystal Fry-Vanuch

Member

Head of Government Affairs, Policy and Public Affairs, Americas, Fujifilm Holdings America Corp

Mike Gaffney

Member

Exec, Cellphire Therapeutics, Inc.

Cari Gallman

Secretary

Executive Vice President, General Counsel and Chief Policy Officer, Bristol Myers Squibb Company

Deborah Glasser

Member

Head Specialty Care North America and U.S. Country Lead, Sanofi

John Glasspool

Member

CEO, VarmX

Jennifer Good, CPA

Member

Co-Founder, President & CEO, Trevi Therapeutics, Inc.

Steve Harr, MD

Member

President & CEO, Sana Biotechnology, Inc.

Paul J. Hastings

Member

CEO, Nkarta, Inc.

Rachel Haurwitz, PhD

Member

President & CEO, Caribou Biosciences, Inc.

Kent Hawryluk

Member

President/CEO, MBX Biosciences, Inc.

John Hess

Member

Sr. VP, Americas, Chiesi USA, Inc.

Cristin Hubbard

Member

Executive Vice President and Chief Commercial Officer, BioMarin Pharmaceutical, Inc.

Mike Huckman

Member

Senior Advisor, Executive Communications, Real Chemistry

Mohamed Issa

Member

Executive Vice President and Head of U.S. Oncology, Incyte Corporation

Elizabeth Jeffords

Member

CEO, Iolyx Therapeutics

Sabrina M Johnson

Member

President & Chief Executive Officer, Dare Bioscience

Rachna Khosla

Member

Senior Vice President, Head of Business Development, Amgen Inc.

Rachel K. King

Ex Officio Member

Former Co-Founder and CEO, GlycoMimetics, Chair Emeritus, BIO

Neil Kumar, PhD

Member

CEO, BridgeBio Pharma

Joseph LaRosa, Esq

Member

Executive Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.

Chris Leibman

Member

SVP, Chief Access Officer, Biogen

Jeremy M. Levin, DPhil, MB BChir

Member

CEO, Ovid Therapeutics Inc.

Sandy Macrae, MB, PhD

Member

CEO, Sangamo Therapeutics, Inc.

John Maraganore, PhD

Ex Officio Member

Chair Emeritus, Chair Emeritus, BIO

Reenie McCarthy

Member

Chief Executive Officer, Stealth BioTherapeutics

Nathan McCutcheon, MBA

Member

President & CEO, Shionogi & Co., Ltd.

David P. Meeker, MD

Member

Chief Executive Officer, Rhythm Pharmaceuticals, Inc.

Sheila Mikhail

Member

Co-Founder and CEO, M34 Therapeutics

Michael M. Morrissey, PhD

Member

President & CEO, Exelixis, Inc.

Sonia Nath

Member

Partner, Cooley LLP

Jannie Oosthuizen

Member

President, U.S. Human Health, Merck

Julia Owens

Member

Chief Executive Officer, Basking Biosciences, Inc.

Neena Patil

Member

Executive Vice President and Chief Legal Officer, Jazz Pharmaceuticals, Inc.

Cindy Perettie

Member

Executive Vice President, Kite Pharma, a Gilead Company

Richard Pops

Member

Chairman & CEO, Alkermes, Inc.

Mark Pruzanski, MD

Member

Chairman of the Board, Alentis Therapeutics AG

Mike G. Raab

Member

President & Chief Executive Officer, Ardelyx Inc.

Jennifer Restivo

Member

Senior Vice President and Head, Market Access, Bayer Corporation

Wendye Robbins, MD

Member

President & CEO, Incendia Therapeutics, Inc.

Michael J. Ruggiero, JD

Member

SVP, Global Healthcare Policy & External Affairs, CSL Behring

Amit Sachdev

Member

Chief Patient Officer, Vertex Pharmaceuticals Incorporated

Michael Schoen

Member

Strategic Advisor and Special Assistant to the CEO, BeOne Medicines

Harout Semerjian

Member

President and CEO, Geron Corporation

R. Scott Struthers, PhD

Member

Founder & CEO, Crinetics Pharmaceuticals Inc.

Eddie J. Sullivan Ph.D, PhD

Member

President & Co-Founder, SAB Biotherapeutics

Nina Tandon

Member

Co-Founder & CEO, EpiBone, Inc.

Tolga Tanguler

Member

Chief Commercial Officer, Alnylam Pharmaceuticals, Inc.

Silvia Taylor

Member

Executive Vice President, Chief Corporate Affairs Officer, and Head of Novavax Sweden, Novavax, Inc

Nolan Townsend

Member

CEO, Lexeo Therapeutics

Neil Warma

Member

President & CEO, ProMIS Neurosciences

Ryan Watts, PhD

Member

Chief Executive Officer, Denali Therapeutics Inc.

Leslie J. Williams, MBA

Member

President & CEO, DaCapo Brainscience, Inc.

Rick E. Winningham

Member

Chairman & Chief Executive Officer, Theravance Biopharma US, Inc.

Ilya Yuffa

Member

Executive Vice President and President of Lilly USA, Eli Lilly and Company

Daniel de Boer

Member

Chief Executive Officer, ProQR Therapeutics